Bio-Path Holdings to Initiate Development of Liposomal Bcl-2 in Follicular Lymphoma – Company Broadening its Pipeline with Second Product Candidate – Bio_Path_Initiates_Devel_Liposomal_Bcl_2
Leave a Reply